The drug, called retatrutide, showed significant weight loss and improvements in a key measure of blood sugar levels.
Eli Lilly delays FDA filing for next-generation weight-loss drug retatrutide
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!